When activated, PI3K/Akt leads to the inhibition of pro-apoptotic factors, and stimulates mTOR (mammalian target of rapamycin), promoting cell growth and protein synthesis—processes essential for tumor development and metastatic potential in CRC (90). Here, AKT1 is linked to neoplasm.